{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:55:59Z","timestamp":1791575759100,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005054","name":"Nantong University","doi-asserted-by":"publisher","award":["2025LY030"],"award-info":[{"award-number":["2025LY030"]}],"id":[{"id":"10.13039\/501100005054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009576","name":"Nantong City Health Commission","doi-asserted-by":"publisher","award":["MS2025049"],"award-info":[{"award-number":["MS2025049"]}],"id":[{"id":"10.13039\/501100009576","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["academicradiology.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.acra.2026.09.023","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:34:15Z","timestamp":1791200055000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early Prediction of Insufficient Response to Ursodeoxycholic Acid: A Multimodal Model Based on Radiomics and Clinical Indicators"],"prefix":"10.1016","author":[{"given":"Yanan","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhui","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4037-3712","authenticated-orcid":false,"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acra.2026.09.023_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-021-10276-6","article-title":"APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis","volume":"16","author":"You","year":"2022","journal-title":"Hepatol Int"},{"key":"10.1016\/j.acra.2026.09.023_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis","volume":"67","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.acra.2026.09.023_bib3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 practice guidance from the American Association for the Study of Liver Diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.acra.2026.09.023_bib4","article-title":"Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitis","volume":"6","author":"Roberts","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.acra.2026.09.023_bib5","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-025-04138-w","article-title":"Early assessment of treatment response in primary biliary cholangitis: key to timely management","volume":"25","author":"Koky","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.acra.2026.09.023_bib6","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2147\/IJGM.S493132","article-title":"Application value of novel inflammatory indicators in response to ursodeoxycholic acid therapy in patients with primary biliary cholangitis","volume":"18","author":"Liu","year":"2025","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.acra.2026.09.023_bib7","first-page":"187","article-title":"Predictive model of ursodeoxycholic acid treatment response in primary biliary cholangitis","volume":"9","author":"Shu","year":"2021","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.acra.2026.09.023_bib8","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-026-04665-0","article-title":"Primary biliary cholangitis with inflammation involving zone 3 of the liver has a poor response to ursodeoxycholic acid treatment: a retrospective cohort study","volume":"26","author":"Zhong","year":"2026","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.acra.2026.09.023_bib9","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","article-title":"Radiomics: the bridge between medical imaging and personalized medicine","volume":"14","author":"Lambin","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.acra.2026.09.023_bib10","doi-asserted-by":"crossref","DOI":"10.1186\/s12880-024-01398-y","article-title":"Machine learning model for non-alcoholic steatohepatitis diagnosis based on ultrasound radiomics","volume":"24","author":"Xia","year":"2024","journal-title":"BMC Med Imaging"},{"key":"10.1016\/j.acra.2026.09.023_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/hepr.13966","article-title":"Development and validation of machine learning model for predicting treatment responders in patients with primary biliary cholangitis","volume":"54","author":"Kimura","year":"2024","journal-title":"Hepatol Res"},{"key":"10.1016\/j.acra.2026.09.023_bib12","first-page":"1770","article-title":"Oncology Intervention Committee of Chinese Research Hospital Society; National Health Commission Capacity Building and Continuing Education Expert Committee on Ultrasonic Diagnosis. Guideline for ultrasonic diagnosis of liver diseases [J]","volume":"37","author":"Chinese Society of Ultrasound in Medicine","year":"2021","journal-title":"J Clin Hepatol"},{"key":"10.1016\/j.acra.2026.09.023_bib13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1148\/115.1.157","article-title":"Ultrasonographic determination of the splenic size and its clinical usefulness in various liver diseases","volume":"115","author":"Koga","year":"1975","journal-title":"Radiology"},{"key":"10.1016\/j.acra.2026.09.023_bib14","first-page":"1257","article-title":"Primary biliary cirrhosis","volume":"60","author":"Scheuer","year":"1967","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.acra.2026.09.023_bib15","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s12072-021-10163-0","article-title":"Paris II and Rotterdam criteria are the best predictors of outcomes in patients with primary biliary cholangitis in Japan","volume":"15","author":"Kimura","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.acra.2026.09.023_bib16","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1148\/radiol.2020191145","article-title":"The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping","volume":"295","author":"Zwanenburg","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.acra.2026.09.023_bib17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jhep.2019.04.001","article-title":"Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis","volume":"71","author":"Harms","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.acra.2026.09.023_bib18","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22428","article-title":"Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis","volume":"48","author":"Corpechot","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.acra.2026.09.023_bib19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.gastro.2004.11.009","article-title":"The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis","volume":"128","author":"Corpechot","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.acra.2026.09.023_bib20","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1007\/s00535-013-0903-1","article-title":"Biochemical response to ursodeoxycholic acid predicts survival in a North American cohort of primary biliary cirrhosis patients","volume":"49","author":"Lammert","year":"2014","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.acra.2026.09.023_bib21","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s10620-022-07654-x","article-title":"Response to ursodeoxycholic acid may be assessed earlier to allow second-line therapy in patients with unresponsive primary biliary cholangitis","volume":"68","author":"Can\u00e7ado","year":"2023","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.acra.2026.09.023_bib22","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/liv.15592","article-title":"Optimizing therapy in primary biliary cholangitis: alkaline phosphatase at six months identifies one-year non-responders and predicts survival","volume":"43","author":"Murillo Perez","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.acra.2026.09.023_bib23","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.28017","article-title":"The UK-PBC risk scores: derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis","volume":"63","author":"Carbone","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.acra.2026.09.023_bib24","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2517319122","article-title":"Kupffer cells are essential for platelet-mediated thrombopoietin generation in the liver","volume":"122","author":"Karakas","year":"2025","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.acra.2026.09.023_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-82854-1","article-title":"Development and external validation of an early prediction model to identify irresponsive patients and prognosis of UDCA treatment in primary biliary cholangitis","volume":"14","author":"Zhu","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.acra.2026.09.023_bib26","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1007\/s00330-023-10080-w","article-title":"Noninvasive prediction of insufficient biochemical response after ursodeoxycholic acid treatment in patients with primary biliary cholangitis based on pretreatment nonenhanced MRI","volume":"34","author":"Zhang","year":"2024","journal-title":"Eur Radiol"},{"key":"10.1016\/j.acra.2026.09.023_bib27","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/apt.15533","article-title":"Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response","volume":"50","author":"Murillo Perez","year":"2019","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633226007592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633226007592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:46:49Z","timestamp":1791575209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633226007592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":27,"alternative-id":["S1076633226007592"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2026.09.023","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Prediction of Insufficient Response to Ursodeoxycholic Acid: A Multimodal Model Based on Radiomics and Clinical Indicators","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2026.09.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Association of Academic Radiology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}